Macrophage migration inhibitory factor: A regulator of innate immunity

被引：1470

作者：

Calandra, T ^{[1
]}

Roger, T ^{[1
]}

机构：

[1] CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland

来源：

NATURE REVIEWS IMMUNOLOGY | 2003年 / 3卷 / 10期

关键词：

D O I：

10.1038/nri1200

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

For more than a quarter of a century, macrophage migration inhibitory factor (MIF) has been a mysterious cytokine. In recent years, MIF has assumed an important role as a pivotal regulator of innate immunity. MIF is an integral component of the host antimicrobial alarm system and stress response that promotes the pro-inflammatory functions of immune cells. A rapidly increasing amount of literature indicates that MIF is implicated in the pathogenesis of sepsis, and inflammatory and autoimmune diseases, suggesting that MIF-directed therapies might offer new treatment opportunities for human diseases in the future.

引用

页码：791 / 800

页数：10

共 127 条

[1] Regulation of the CTL response by macrophage migration inhibitory factor [J].

Abe, R ;

Peng, T ;

Sailors, J ;

Bucala, R ;

Metz, CN .

JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :747-753

[2] An essential regulatory role for macrophage migration inhibitory factor in T-cell activation [J].

Bacher, M ;

Metz, CN ;

Calandra, T ;

Mayer, K ;

Chesney, J ;

Lohoff, M ;

Gemsa, D ;

Donnelly, T ;

Bucala, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7849-7854

[3]

Bacher M, 1997, AM J PATHOL, V150, P235

[4] A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis [J].

Baugh, JA ;

Chitnis, S ;

Donnelly, SC ;

Monteiro, J ;

Lin, X ;

Plant, BJ ;

Wolfe, F ;

Gregersen, PK ;

Bucala, R .

GENES AND IMMUNITY, 2002, 3 (03) :170-176

[5] Macrophage migration inhibitory factor [J].

Baugh, JA ;

Bucala, R .

CRITICAL CARE MEDICINE, 2002, 30 (01) :S27-S35

[6] Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness [J].

Beishuizen, A ;

Thijs, LG ;

Haanen, C ;

Vermes, I .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (06) :2811-2816

[7] Biochemical and nutational investigations of the enzymatic activity of macrophage migration inhibitory factor [J].

Bendrat, K ;

AlAbed, Y ;

Callaway, DJE ;

Peng, T ;

Calandra, T ;

Metz, CN ;

Bucala, R .

BIOCHEMISTRY, 1997, 36 (49) :15356-15362

[8] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].

BERNHAGEN, J ;

CALANDRA, T ;

MITCHELL, RA ;

MARTIN, SB ;

TRACEY, KJ ;

VOELTER, W ;

MANOGUE, KR ;

CERAMI, A ;

BUCALA, R .

NATURE, 1993, 365 (6448) :756-759

[9] PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) [J].

BERNHAGEN, J ;

MITCHELL, RA ;

CALANDRA, T ;

VOELTER, W ;

CERAMI, A ;

BUCALA, R .

BIOCHEMISTRY, 1994, 33 (47) :14144-14155

[10] An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction [J].

Bernhagen, J ;

Bacher, M ;

Calandra, T ;

Metz, CN ;

Doty, SB ;

Donnelly, T ;

Bucala, R .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :277-282

← 1 2 3 4 5 6 7 8 9 10 →